December 30, 2020
Sean J. Shapiro was Vice President of Commercial Operations at Viveve Inc., a Women’s Health Company that manufactures patented CMRF Technology, where he recruited a sales team that generated approximately $11 million in revenue in the year of launch.
Prior to this, Sean J. Shapiro served as Senior Director of the North America Device Division at Merz, where he successfully led a team of over 60 sales professionals and helped launch Cellfina, a cellulite treatment device that generated $15 million in sales during the first year, along with Ultherapy, an industry-leading skin tightening device.
Brad Hauser, Soliton’s President, and CEO, commented, “We are very excited to have Sean join our team during this pivotal time for the company as we anticipate clearance of our 510(k) application for cellulite reduction during the first quarter of 2021. Sean is a seasoned sales executive who has successfully launched several aesthetic devices in the industry, and we look forward to leveraging his extensive experience as we prepare for the commercial launch of our RAP technology during the first half of next year.”
Shapiro said, “I am truly looking forward to being a part of an established veteran leadership team with such innovative technology that will provide practitioners and patients superior results in cellulite and tattoo removal. I am also excited to become a key contributor to the commercial success and build a talented and determined sales organization.”
